Ben Venue Laboratories, Inc. Named Recipient of the Governor's Award for Outstanding Achievement in Environmental S...(ug products for theglobal pharmaceutical...),Health

Date:12/8/2008

ug products for the global pharmaceutical industry. It also markets its own line of generic sterile injectables to hospitals and alternate care markets in North America through its Bedford Laboratories division -- currently offering a variety of products including oncology, cardiovascular, anesthesia, antipsychotic and various other products. BVL has been under contract with the National Cancer Institute since 1967 to develop parenteral dosage forms for many anticancer agents. It has also manufactured various AIDS-specific drugs in conjunction with the NCI. Ben Venue is located in Bedford, Ohio and employs more than 1,100 people. For more information on Ben Venue Laboratories, visit www.benvenue.com.

Ben Venue is a U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.

About Boehringer Ingelheim

Boehringer Ingelheim Corporation based in Ridgefield, CT, is the US headquarters to seven subsidiaries and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and approximately 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information on Boehringer Ingelheim, please visit http://us.boehringer-ingelh
'/>"/>

SOURCE Ben Venue Laboratories, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31
2. Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income
3. PaperThin Experiences Record Growth : Grows Revenues, Expands Channel, and Maintains 95%+ Subscription Renewal Rate
4. Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter
5. AMN Survey: Nurses to Have Bigger Impact on Hospital Revenue
6. The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance
7. Ocean Blue Plastic Surgery to Open This Month on Brickell Avenue
8. TransUnion Revenue Manager Addresses Red Flags Regulations
9. Medifast Diversified Business Model Drives Strong Revenue and Earnings Growth for the Third Quarter of 2008
10. Volcano Reports 40 Percent Growth in Quarterly Revenues
11. drugstore.com inc. Reports Solid Revenue Growth and Record Gross Margins in the Third Quarter of 2008